166 related articles for article (PubMed ID: 23594419)
1. Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature.
Arends M; van Dussen L; Biegstraaten M; Hollak CE
Br J Haematol; 2013 Jun; 161(6):832-42. PubMed ID: 23594419
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.
Rosenbloom BE; Cappellini MD; Weinreb NJ; Dragosky M; Revel-Vilk S; Batista JL; Sekulic D; Mistry PK
Am J Hematol; 2022 Oct; 97(10):1337-1347. PubMed ID: 36054609
[TBL] [Abstract][Full Text] [Related]
3. Synchronous multiple myeloma and Gaucher disease.
Monge J; Chadburn A; Gergis U
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):42-45. PubMed ID: 31622574
[TBL] [Abstract][Full Text] [Related]
4. Gaucher disease and monoclonal gammopathy: a report of 17 cases and impact of therapy.
Grosbois B; Rose C; Noël E; Serratrice Cde R; Dobbelaere D; Gressin V; Chérin P; Hartmann A; Javier RM; Clerson P; Hachulla E; Jaussaud R;
Blood Cells Mol Dis; 2009; 43(1):138-9. PubMed ID: 19427246
[No Abstract] [Full Text] [Related]
5. Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.
Hughes D; Cappellini MD; Berger M; Van Droogenbroeck J; de Fost M; Janic D; Marinakis T; Rosenbaum H; Villarubia J; Zhukovskaya E; Hollak C
Br J Haematol; 2007 Sep; 138(6):676-86. PubMed ID: 17655728
[TBL] [Abstract][Full Text] [Related]
6. Effect of treatment on biclonal gammopathy associated with Gaucher disease.
Decaux O; Ruelland A; Grosbois B
J Inherit Metab Dis; 2007 Oct; 30(5):824. PubMed ID: 17879146
[TBL] [Abstract][Full Text] [Related]
7. Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism.
Mistry PK; Taddei T; vom Dahl S; Rosenbloom BE
Crit Rev Oncog; 2013; 18(3):235-46. PubMed ID: 23510066
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry.
Nguyen Y; Stirnemann J; Lautredoux F; Cador B; Bengherbia M; Yousfi K; Hamroun D; Astudillo L; Billette de Villemeur T; Brassier A; Camou F; Dalbies F; Dobbelaere D; Gaches F; Leguy-Seguin V; Masseau A; Pers YM; Pichard S; Serratrice C; Berger MG; Fantin B; Belmatoug N; On Behalf Of The French Evaluation Of Gaucher Disease Treatment Committee
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32069933
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.
de Fost M; Out TA; de Wilde FA; Tjin EP; Pals ST; van Oers MH; Boot RG; Aerts JF; Maas M; Vom Dahl S; Hollak CE
Ann Hematol; 2008 Jun; 87(6):439-49. PubMed ID: 18274746
[TBL] [Abstract][Full Text] [Related]
10. Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.
Nair S; Branagan AR; Liu J; Boddupalli CS; Mistry PK; Dhodapkar MV
N Engl J Med; 2016 Feb; 374(6):555-61. PubMed ID: 26863356
[TBL] [Abstract][Full Text] [Related]
11. Silicone gel implants and monoclonal gammopathies: three cases of multiple myeloma and the prevalence of multiple myeloma and monoclonal gammopathy of undetermined significance.
Silverman S; Vescio R; Silver D; Renner S; Weiner S; Berenson J
Curr Top Microbiol Immunol; 1996; 210():367-74. PubMed ID: 8565579
[No Abstract] [Full Text] [Related]
12. Triangular approach for the diagnosis of monoclonal gammopathy in malignancies.
Kulkarni SA; Shrikhande AV
Indian J Cancer; 2002 Jun; 39(2):45-54. PubMed ID: 12789724
[TBL] [Abstract][Full Text] [Related]
13. Gaucher disease and cancer incidence: a study from the Gaucher Registry.
Rosenbloom BE; Weinreb NJ; Zimran A; Kacena KA; Charrow J; Ward E
Blood; 2005 Jun; 105(12):4569-72. PubMed ID: 15718419
[TBL] [Abstract][Full Text] [Related]
14. A patient with Gaucher disease and plasma cell dyscrasia: bidirectional impact.
Zimran A; Ruchlemer R; Revel-Vilk S
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):389-394. PubMed ID: 33275748
[TBL] [Abstract][Full Text] [Related]
15. Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational study.
Biegstraaten M; Mengel E; Maródi L; Petakov M; Niederau C; Giraldo P; Hughes D; Mrsic M; Mehta A; Hollak CE; van Schaik IN
Brain; 2010 Oct; 133(10):2909-19. PubMed ID: 20693542
[TBL] [Abstract][Full Text] [Related]
16. Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic.
Zimran A; Liphshitz I; Barchana M; Abrahamov A; Elstein D
Blood Cells Mol Dis; 2005; 34(3):197-200. PubMed ID: 15885601
[TBL] [Abstract][Full Text] [Related]
17. Effect of enzyme replacement therapy on gammopathies in Gaucher disease.
Brautbar A; Elstein D; Pines G; Abrahamov A; Zimran A
Blood Cells Mol Dis; 2004; 32(1):214-7. PubMed ID: 14757437
[TBL] [Abstract][Full Text] [Related]
18. Type I Gaucher disease with severe skeletal destruction, extraosseous extension, and monoclonal gammopathy.
Kaloterakis A; Cholongitas E; Pantelis E; Papadimitriou C; Durakis S; Filiotou A
Am J Hematol; 2004 Dec; 77(4):377-80. PubMed ID: 15551278
[TBL] [Abstract][Full Text] [Related]
19. Gaucher disease and myeloma.
Ayto R; Hughes DA
Crit Rev Oncog; 2013; 18(3):247-68. PubMed ID: 23510067
[TBL] [Abstract][Full Text] [Related]
20. [Biclonal gammapathy in type I Gaucher disease].
Kaminsky P; Klein M; Jacob C; Deibener J; Duc M
Presse Med; 1995 Oct; 24(30):1400. PubMed ID: 8545320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
